투자판단관련주요경영사항(임상시험계획승인신청) (경증에서 중등증 아토피 피부염 치료 후보물질 IN-115314 임상 1b상 임상시험계획(IND) 미국 식품의약국(FDA) 제출)[코]
Received: 4/1/2026 · Reporter: HK이노엔
A summary for this filing type is not yet available. Please refer to the original DART filing.
🏢 Past 12 months filing pattern (this company)
- Total filings
- 39 filings
- Same category
- 27 filings
- Previous same-category filing
- 7/29/2026
- Corrections / withdrawals
- 1 filing
Filing source / License
The original PDF/HTML of this filing is provided by FSS DART. MarketBubbles displays only metadata (title, receipt number, type, reporter) and a rule-based summary; we do not mirror the original PDF body (per FSS ToS).